1. Home
  2. EDD vs BWAY Comparison

EDD vs BWAY Comparison

Compare EDD & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Morgan Stanley Emerging Markets Domestic Debt Fund Inc.

EDD

Morgan Stanley Emerging Markets Domestic Debt Fund Inc.

HOLD

Current Price

$6.08

Market Cap

380.9M

Sector

Finance

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$21.78

Market Cap

410.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDD
BWAY
Founded
2007
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
380.9M
410.4M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
EDD
BWAY
Price
$6.08
$21.78
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$26.50
AVG Volume (30 Days)
254.3K
119.6K
Earning Date
01-01-0001
03-10-2026
Dividend Yield
7.52%
N/A
EPS Growth
N/A
213.09
EPS
N/A
0.13
Revenue
N/A
$49,094,000.00
Revenue This Year
N/A
$330.76
Revenue Next Year
N/A
$22.24
P/E Ratio
N/A
$67.54
Revenue Growth
N/A
27.08
52 Week Low
$4.22
$7.84
52 Week High
$4.95
$25.65

Technical Indicators

Market Signals
Indicator
EDD
BWAY
Relative Strength Index (RSI) 73.78 46.06
Support Level $5.75 $20.34
Resistance Level $5.94 $25.65
Average True Range (ATR) 0.07 1.38
MACD 0.01 -0.53
Stochastic Oscillator 98.57 20.90

Price Performance

Historical Comparison
EDD
BWAY

About EDD Morgan Stanley Emerging Markets Domestic Debt Fund Inc.

Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: